$CBST Oppenheimer Comments On Cubist Pharmaceuticals As Merck Is Nearing An $8B Takeover http://www.smarteranalyst.com/2014/12/08/oppenheimer-reiterates-outperform-on-cubist-pharmaceuticals-shares-sees-18-downside-for-the-stock/